GGrantIndex
Sort

85,873 grants matching alzheimers

High Resolution MRSI for Alzheimer's Disease and Related Dementias

$789,648
Vincent A Magnotta · University Of Iowa · R01 · FY2024 · AG

The Relationship Between Brain Macrophages and Cognitive Dysfunction in Systemic Lupus Erythematosus

$789,602
Carla M Cuda · Northwestern University At Chicago · R01 · FY2023 · AI

Longitudinal imaging of microglial activation in different clinical variants of Alzheimer's disease

$789,578
Scott A Small · Columbia University Health Sciences · R01 · FY2024 · AG

Dissemination & Implementation Core

$789,577
Laura N. Gitlin · Brown University · U54 · FY2021 · AG

Biomarkers of Cognitive Decline among Normal Individuals: the BIOCARD cohort

$789,575
Marilyn S Albert · Johns Hopkins University · U01 · FY2011 · AG

Mechanisms underlying the neuroprotective effect of nasal administration of anti-CD3 in AD mouse models

$789,540
Howard L Weiner · Brigham And Women'S Hospital · R01 · FY2025 · AG

A Squirrel Monkey Model of Alzheimer’s Disease: Developing Behavioral, Blood, and CSF Biomarkers

$789,521
William D Hopkins · University Of Tx Md Anderson Can Ctr · R33 · FY2025 · AG

Impact of Care Delivery and Therapeutic Changes on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias

$789,438
John Hsu · Massachusetts General Hospital · U01 · FY2025 · AG

Core B - Clinical Core

$789,415
David A Wolk · University Of Pennsylvania · P30 · FY2017 · AG

Columbia Center for Active Life of Minority Elders

$789,369
Columbia University Health Sciences · P30 · FY2005 · AG

I-CARE 2 RCT: Mobile Telehealth to Reduce Alzheimer's-related Symptoms for Caregivers and Patients

$789,359
Richard J Holden · Trustees Of Indiana University · R01 · FY2024 · AG

I-CARE 2 RCT: Mobile Telehealth to Reduce Alzheimer's-related Symptoms for Caregivers and Patients

$789,359
Richard J Holden · Trustees Of Indiana University · R01 · FY2023 · AG

Social Determinants of Health, Resilience, and Premature Cognitive Aging in End-stage Renal Disease

$789,298
Mara A. McAdams Demarco · New York University School Of Medicine · R01 · FY2025 · AG

Blood mitochondrial DNA biomarkers of midlife cognitive decline and adverse brain imaging changes - A longitudinal investigation in the CARDIA population‐based cohort study

$789,288
Andrea Baccarelli · Columbia University Health Sciences · R01 · FY2022 · AG

Diagnostic and prognostic certainty in behavioral variant frontotemporal dementia

$789,268
David C Perry · University Of California, San Francisco · R01 · FY2025 · AG

Role of EphA1/A2 domain-domain and -membrane interactions for receptor specificity and Blood Brain Barrier dysfunction

$789,248
Matthias Buck · Case Western Reserve University · R01 · FY2025 · AG

The Role of Immunoproteasome Function in Alzheimer's Disease and Aging

$789,225
Natura Myeku · Columbia University Health Sciences · R01 · FY2024 · AG

J: NRSA Training Core

$789,195
Janice Lynn Gabrilove · Icahn School Of Medicine At Mount Sinai · TL1 · FY2023 · TR

Neuroinflammation, Perineural Nets, and Postoperative Delirium

$789,176
Shiqian Shen · Massachusetts General Hospital · R01 · FY2025 · AG

Role of PDE2A in mitochondrial dysfunction in Alzheimer’s disease

$789,176
Ying Xu · Rbhs-New Jersey Medical School · R01 · FY2022 · AG

A spatially resolved joint cortical metabolome and proteome in aging and menopause for the rhesus macaque

$789,150
Anita A Disney · Duke University · R01 · FY2023 · AG

Amyloid Inhibiting Agent for Treatment of Alzheimer's

$789,141
Proteotech, Inc. · R44 · FY2001 · AG

Defining TBK1-associated autophagy networks in neurons

$789,130
Daniel Adam Mordes · University Of California, San Francisco · R01 · FY2024 · AG

Reversing Microglial Inflammarafts and Mitochondrial Dysfunction in Alzheimer's Disease

$789,121
Yury Miller · University Of California, San Diego · R01 · FY2023 · AG

Occupational transitions across the lifecourse and dementia risk: evaluating unemployment, occupational complexity using sequence analysis

$789,078
Anusha Murthy Vable · University Of California, San Francisco · R01 · FY2022 · AG